The opioid receptors as targets for drug abuse medication

被引:19
|
作者
Noble, Florence [1 ,2 ,3 ]
Lenoir, Magalie [1 ,2 ,3 ]
Marie, Nicolas [1 ,2 ,3 ]
机构
[1] CNRS, Paris, France
[2] INSERM, Paris, France
[3] Univ Paris 05, Paris, France
关键词
CONDITIONED PLACE PREFERENCE; MESSENGER-RNA EXPRESSION; VENTRAL TEGMENTAL AREA; INDUCED BEHAVIORAL SENSITIZATION; POSITIVE ALLOSTERIC MODULATORS; RAT NUCLEUS-ACCUMBENS; PROOPIOMELANOCORTIN GENE-EXPRESSION; NICOTINE-INDUCED ANTINOCICEPTION; CHRONIC BUPRENORPHINE TREATMENT; POSITRON-EMISSION-TOMOGRAPHY;
D O I
10.1111/bph.13190
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The endogenous opioid system is largely expressed in the brain, and both endogenous opioid peptides and receptors are present in areas associated with reward and motivation. It is well known that this endogenous system plays a key role in many aspects of addictive behaviours. The present review summarizes the modifications of the opioid system induced by chronic treatment with drugs of abuse reported in preclinical and clinical studies, as well as the action of opioid antagonists and agonists on the reinforcing effects of drugs of abuse, with therapeutic perspectives. We have focused on the effects of chronic psychostimulants, alcohol and nicotine exposure. Taken together, the changes in both opioid peptides and opioid receptors in different brain structures following acute or chronic exposure to these drugs of abuse clearly identify the opioid system as a potential target for the development of effective pharmacotherapy for the treatment of addiction and the prevention of relapse.
引用
收藏
页码:3964 / 3979
页数:16
相关论文
共 50 条
  • [41] CHRACTERIZATION OF THE PHARMACOLOGICAL TARGETS OF MEPHEDRONE: A NEW DRUG OF ABUSE
    Martinez-Clemente, J.
    Escubedo, E.
    Pubill, D.
    Camarasa, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 302 - 302
  • [42] Ketamine Enantiomers Differentially Interact With Opioid Receptors to Modulate Opioid-Dependent Behavior and Opioid Abuse Liability
    Bonaventura, Jordi
    Lam, Sherry
    Sanchez-Soto, Marta
    Fredriksson, Ida
    Gomez, Juan
    Applebey, Sarah
    Boehm, Matthew
    Pignatelli, Marco
    Tejeda, Hugo
    Sibley, David
    Zarate, Carlos
    Michaelides, Mike
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 198 - 198
  • [43] Pharmacotherapy for alcoholism: Novel targets for medication development in glycine receptors
    Davies, D. L.
    Trudell, J. R.
    Crawford, D. K.
    Perkins, D. I.
    Shen, Y.
    Li, K. X.
    Alkana, R. L.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2006, 30 (06) : 263A - 263A
  • [44] Chemokines and their receptors: Drug targets in immunity and inflammation
    Viola, Antonella
    Luster, Andrew D.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2008, 48 : 171 - 197
  • [45] GABA(B) receptors: Targets for drug development
    Kerr, DIB
    Ong, J
    DRUG DISCOVERY TODAY, 1996, 1 (09) : 371 - 380
  • [46] Bile acid receptors as targets for drug development
    Schaap, Frank G.
    Trauner, Michael
    Jansen, Peter L. M.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2014, 11 (01) : 55 - 67
  • [47] Muscarinic acetylcholine receptors as CNS drug targets
    Langmead, Christopher J.
    Watson, Jeannette
    Reavill, Charlie
    PHARMACOLOGY & THERAPEUTICS, 2008, 117 (02) : 232 - 243
  • [48] GABA receptors and transporters as drug targets in epilepsy
    Schousboe, A
    JOURNAL OF NEUROCHEMISTRY, 2000, 74 : S5 - S5
  • [49] Purinergic and pyrimidinergic receptors as potential drug targets
    Williams, M
    Jarvis, MF
    BIOCHEMICAL PHARMACOLOGY, 2000, 59 (10) : 1173 - 1185
  • [50] Nuclear receptors as potential drug targets in osteoarthritis
    Sun, Margaret Man-Ger
    Beier, Frank
    Ratneswaran, Anusha
    CURRENT OPINION IN PHARMACOLOGY, 2018, 40 : 81 - 86